Predicting Quality of Life from Symptom Experience and Symptom Management Behaviors in Women with Ovarian Cancer Receiving Chemotherapy: A Cross-Sectional Study.
DOI:
https://doi.org/10.60099/prijnr.2026.279388Keywords:
Chemotherapy, Ovarian cancer, Quality of life, Self-management, Symptom experience, Symptom managementAbstract
Women with ovarian cancer receiving chemotherapy commonly experience multiple distressing symptoms that adversely affect quality of life; however, empirical evidence on symptom experiences and management behaviors, and their influence on quality of life among this population in Thailand, remains limited. Thus, this cross-sectional study in Thailand aimed to describe these experiences and behaviors, to predict quality of life in women with ovarian cancer receiving chemotherapy. Ninety-six women with ovarian cancer receiving chemotherapy at a university hospital were recruited using purposive sampling. Instruments used were the M.D. Anderson Symptom Inventory–Ovarian Cancer, a Modified Self-Care Diary, and the Functional Assessment of Cancer Therapy–Ovarian. Data were analyzed using descriptive statistics, Spearman’s rho correlation, and hierarchical multiple regression.
Participants experienced multiple concurrent symptoms, with numbness/tingling and fatigue reported most frequently. Overall symptom severity and interference were mild; however, neuropathy and fatigue were perceived as the most severe symptoms. Symptom management effectiveness was moderate, with hair loss and nausea showing the greatest improvement, whereas neuropathy remained poorly managed. Overall quality of life was rated as good.
Symptom experiences—occurrence, severity, and interference—were significantly associated with overall quality of life. However, the association between symptom management effectiveness and quality of life was not significant. Combined, symptom experiences and management effectiveness explained 28.6% of the variance in quality of life. Only symptom interference was a significant negative predictor of quality of life. These findings emphasize the need for nurses to conduct routine and comprehensive symptom assessments and implement targeted interventions, particularly to reduce symptom interference, neuropathy, and fatigue, to improve quality of life in women with ovarian cancer receiving chemotherapy.
References
International Agency for Research on Cancer, World Health Organization. Global cancer observatory: WHO South East Asia Region (SEARO) [Internet]. 2022 [cited 2024 Mar 13]. Available from: https://gco.iarc.who.int/media/globocan/factsheets/populations/995-who-southeast-asia-searo-fact-sheet.pdf
National Cancer Institute, Department of Medical Services, Ministry of Public Health Thailand. Hospital-based cancer registry 2022 [Internet]. 2022 [cited 2024 Mar 13]. Available from: https://www.nci.go.th/th/cancer_record/download/Hosbased-2022-1.pdf (in Thai).
Alrosan K, Alrosan AZ, Heilat GB, Alrousan AF, Gammoh OS, Alqudah A, et al. Treatment of ovarian cancer: from the past to the new era (Review). Oncol Lett. 2025; 30(2):384. doi: 10.3892/ol.2025.15130.
Feng Y, Lin T, Liu X, Guo X, Chen J, Deng X. A longitudinal study of symptom cluster latent profiles in ovarian cancer patients undergoing chemotherapy. Cancer Med. 2024;13(7): e7139. doi: 10.1002/cam4.7139.
Armstrong DK, Alvarez RD, Bakkum-Gamez JN, Barroilhet L, Behbakht K, Berchuck A, et al. Ovarian cancer, version 2.2020, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2021;19(2):191–226. doi: 10.6004/jnccn.2021.0007.
Nechuta S, Lu W, Chen Z, Zheng Y, Gu K, Cai H, et al. Vitamin supplement use during breast cancer treatment and survival: a prospective cohort study. Cancer Epidemiol Biomarkers Prev. 2011;20(2):262–71.doi: 10.1158/1055-9965.EPI-10-1072.
Witwaranukool P, Seedadard R, Krongthaeo S, Leaungsomnapa Y. Quality of life and associated factors among cancer patients receiving chemotherapy during the COVID-19 pandemic in Thailand. Int J Environ Res Public Health. 2024;21(3):317. doi: 10.3390/ijerph21030317.
Wilailak S, Lertkhachonsuk AA, Lohacharoenvanich N, Luengsukcharoen SC, Jirajaras M, Likitanasombat P, et al. Quality of life in gynecologic cancer survivors compared to healthy check-up women. J Gynecol Oncol. 2011;22(2): 103–9. doi: 10.3802/jgo.2011.22.2.103.
Bender MS, Janson SL, Franck LS, Lee KA. Theory of symptom management. In: Smith MJ, Liehr PR, editors. Middle range theory for nursing. New York: Springer Publishing; 2018. pp. 147-77.
Dodd M, Janson S, Facione N, Faucett J, Froelicher ES, Humphreys J, et al. Advancing the science of symptom management. J Adv Nurs. 2001;33(5):668–76. doi: 10.1046/j.1365-2648.2001.01697.x.
Pozzař RA, Hammer MJ, Cooper BA, Kober KM, Chen LM, Paul SM, et al. Symptom clusters in patients with gynecologic cancer receiving chemotherapy. Oncol Nurs Forum. 2021;48(4):441–52. doi: 10.1188/21.ONF.441-452.
Sarkar S, Sahoo PK, Pal R, Mistry T, Mahata S, Chatterjee P, et al. Assessment of quality of life among advanced ovarian cancer patients in a tertiary care hospital in India. Support Care Cancer. 2022;30(4):3371–8. doi: 10.1007/s00520-021-06735-3.
Qiu T, Zhang T, Zhang Y, Qiu X. Prevalence rates of depression, anxiety, and suicidal ideation in patients with ovarian cancer: a systematic review from 1977 to 2024. Int J Psychiatry Med. 2025:912174251350465. doi: 10.1177/00912174251350465.
Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, et al. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol. 1993;11(3):570–9. doi: 10.1200/JCO.1993.11.3.570.
Ferracini AC, Pereira G, de Souza CM, Dos Santos TFC, Sarian LO, Derchain S, et al. Physical and functional well-being and symptoms of ovarian cancer in women undergoing first-line of chemotherapy: a one-year follow-up. Support Care Cancer. 2021;29(12):7421–30. doi: 10.1007/s00520-021-06298-3.
Rha SY, Lee HJ, Lee J. Unmet needs in the physical and daily living domain mediates the influence of symptom experience on the quality of life of gastric cancer patients. Support Care Cancer. 2020;28(3):1419–31. doi: 10. 1007/s00520-019-04954-3.
Akhter T, Pervin S, Goodman A. Quality of life in ovariancancer patients receiving chemotherapy. J Cancer Ther. 2020;11:695-714. doi: 10.4236/jct.2020.1111059.
Aree-Ue S, Youngcharoen P. The 6 Item Cognitive Function Test-Thai Version: psychometric property testing. Rama Nurs J. 2020;26(2):188–202. Available from: https:// he02.tci-thaijo.org/index.php/RNJ/article/view/217560/166539(in Thai).
Brooke P, Bullock R. Validation of a 6 item cognitive impairment test with a view to primary care usage. Int J Geriatr Psychiatry. 1999;14(11):936–40. PMID: 10556864.
Cohen J. Statistical power analysis for the behavioral sciences. New York: Routledge; 2013. doi: 10.4324/9780203771587.
Papadakos J, Barnsley J, Berta W, Rowlands G, Samoil D, Howell D. The association of self-efficacy and health literacy to chemotherapy self-management behaviors and health service utilization. Support Care Cancer. 2022;30(1): 603–13. doi: 10.1007/s00520-021-06466-5.
Sailors MH, Bodurka DC, Gning I, Ramondetta LM, Williams LA, Mendoza TR, et al. Validating the M.D. Anderson Symptom Inventory (MDASI) for use in patients with ovarian cancer. Gynecol Oncol. 2013;130(2):323–8. doi: 10.1016/j.ygyno.2013.05.009.
Cleeland CS, Mendoza TR, Wang XS, Chou C, Harle MT, Morrissey M, et al. Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory. Cancer. 2000;89(7):1634–46. doi: 10.1002/1097-0142(20001001)89:7<1634::aid-cncr29>3.0.co;2-v.
Nail LM, Jones LS, Greene D, Schipper DL, Jensen R. Use and perceived efficacy of self-care activities in patients receiving chemotherapy. Oncol Nurs Forum. 1991;18(5): 883–7. PMID: 1891417.
Sumdaengrit B, Hanucharurnkul S, Dodd MJ, Wilailak S, Vorapongsathorn T, Pongthavornkamol K. Symptom experience and self-care among Thai women with cervical cancer. Pacific Rim Int J Nurs Res. 2010;14(3):203–18. Available from: https://he02.tci-thaijo.org/index.php/PRIJNR/article/view/6282
Jain A, Hariprasad MG, Sharique M, Redhwan MAM. Chemotherapy-induced peripheral neuropathy. Indian J Pharm Educ Res. 2023;57(2):342–53.doi: 10.5530/ijper.57.2.44.
Tang Y, Zhang YY, Wen MB, Li L, Hu HQ, Zeng YH, et al. Patient-reported symptom burden and circulating cytokines undergoing chemotherapy: a pilot study in patients with ovarian cancer. J Gynecol Oncol. 2025;36(2): e17. doi: 10.3802/jgo.2025.36.e17.
Chung KC, Muthutantri A, Goldsmith GG, Watts MR, Brown AE, Patrick DL. Symptom impact and health-related quality of life (HRQoL) assessment by cancer stage: a narrative literature review. BMC Cancer. 2024;24(1):884. doi: 10.1186/s12885-024-12612-z.
Mirzaei S, Bagherian-Sararoudi R, Emami MHD, Izadi R, Sharbafchi MR. The effectiveness of internet-based acceptance and commitment therapy on acceptance of illness, emotion regulation, symptom severity reduction, and symptoms interference with function in patients with breast cancer. BMC Psychiatry. 2025;25(1):599. doi: 10.1186/s12888-025-06823-2.
Phianmongkhol Y, Suwan N. Symptom management in patients with cancer of the female reproductive system receiving chemotherapy. Asian Pac J Cancer Prev. 2008; 9(4):741–5. PMID: 19256770.
Chaichompoo R, Namvongprom A, Pakdevong N, Chuaynum S, Kuawongsa L. Correlation between self-care ability and quality of life of patients with advanced cancer. Nurs Res Inno J. 2024;30(3);308-21. Available from: https://he02.tci-thaijo.org/index.php/RNJ/article/view/265389
Vaingankar JA, Choudhary N, Chong SA, Kumar FDS, Abdin E, Shafie S, et al. Religious affiliation in relation to positive mental health and mental disorders in a multi-ethnic Asian population. Int J Environ Res Public Health. 2021; 18(7):3368. doi: 10.3390/ijerph18073368.
Baczyk G, Pleszewa A, Formanowicz D, Kozlowska KA. Quality of life for Polish women with ovarian cancer during first-line chemotherapy. Healthcare (Basel). 2023; 11(18):2596. doi: 10.3390/healthcare11182596.
Nicholson B, Moraitis AM, Cawley K, Wong B, Echeverria C, Mooney K. Step count and symptom severity during cancer treatment using the Symptom Care at Home digital platform. Support Care Cancer. 2025;33(8):747.doi: 10.1007/s00520-025-09782-2.
Zhang S, Zhang F, Yang F, Yang J, Zhang L, Xie J. Analysis of the status and factors influencing physical activity in patients undergoing ovarian cancer chemotherapy. Front Oncol. 2023;13:1290747. doi: 10.3389/fonc.2023.1290747.
Papadopoulou A, Govina O, Tsatsou I, Mantzorou M, Mantoudi A, Tsiou C, et al. Quality of life, distress, anxiety and depression of ambulatory cancer patients receiving chemotherapy. Med Pharm Rep. 2022;95(4):418–29. doi: 10.15386/mpr-2458.
Wu HJ, Chuang CM, Chien CH, Wang TJ, Liang SY. Changes in depression and sleep quality and associated factors in women receiving chemotherapy for ovarian cancer: An observational study. Cancer Nurs. 2022;45(4):271–9. doi: 10.1097/ncc.0000000000000986.
Oneda E, Abeni C, Zanotti L, Zaina E, Bighè S, Zaniboni A. Chemotherapy-induced neurotoxicity in the treatment of gynecological cancers: state of art and an innovative approach for prevention. World J Clin Oncol. 2021;12(6): 458–67. doi: 10.5306/wjco.v12.i6.458.
Thongprom C, Thasaneesuwan S, Yodchai K. Reducing chemotherapy-induced peripheral neuropathy and enhancing satisfaction through innovative frozen rubber gloves among women with breast cancer: a quasiexperimental study. Pacific Rim Int J Nurs Res. 2025; 29(4):763–76. doi: 10.60099/prijnr.2025.273221.
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2026 Pacific Rim International Journal of Nursing Research
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright: The Pacific Rim International Journal of Nursing Research, Thailand Nursing & Midwifery Council has exclusive rights to publish, reproduce and distribute the manuscript and all contents therein.
.png)
